Den Europæiske Union - bulgarsk - EMA (European Medicines Agency)

viiv healthcare b.v. - долутегравир натрий, рилпивирин хидрохлорид - ХИВ инфекции - Антивирусни средства за системно приложение - juluca е показан за лечение на virus човек Тип 1 (ХИВ-1) инфекция при възрастни, които вирусологически.-потиснат (hiv-1 РНК.

Den Europæiske Union - bulgarsk - EMA (European Medicines Agency)

viiv healthcare b.v. - долутегравир натрий, lamivudine - ХИВ инфекции - Антивирусни средства за системно приложение - dovato е показан за лечение на virus човек Тип 1 (ХИВ-1) инфекция при възрастни и юноши над 12 години с телесно тегло не по-малко от 40 кг, не е известен или очакваната устойчивост на класа инхибитори на интеграза, или lamivudine.

Den Europæiske Union - bulgarsk - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - ХИВ инфекции - Антивирусни средства за системно приложение - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Den Europæiske Union - bulgarsk - EMA (European Medicines Agency)

viiv healthcare b.v. - fostemsavir trometamol - ХИВ инфекции - Антивирусни средства за системно приложение - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

Den Europæiske Union - bulgarsk - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegravir - ХИВ инфекции - Антивирусни средства за системно приложение - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 и 5.

Den Europæiske Union - bulgarsk - EMA (European Medicines Agency)

bavarian nordic a/s - модифицирана ваксиния Анкара - баварски северни (mva-bn) вируси - smallpox vaccine; monkeypox virus - Други вирусни ваксини, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 и 5. Използването на тази ваксина трябва да бъде приложена в съответствие с официалните препоръки.

Den Europæiske Union - bulgarsk - EMA (European Medicines Agency)

ceva santé animale - инактивирана ваксина срещу coxiella burnetii, щам nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

Den Europæiske Union - bulgarsk - EMA (European Medicines Agency)

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - Имунологични средства за суици - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. Друг ключов фактор, допринасящ за разяждането на глиган, skatole, също може да бъде намален като косвен ефект. Агресивното и сексуално (монтажно) поведение също се намалява. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).

Den Europæiske Union - bulgarsk - EMA (European Medicines Agency)

intervet international b.v. - свински цирковирус тип 2 orf2 субединичен антиген - immunologicals for suidae, inactivated viral vaccines - Прасета - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection.  to reduce loss of daily weight gain and mortality associated with pcv2 infection.

Den Europæiske Union - bulgarsk - EMA (European Medicines Agency)

zoetis belgium sa - live recombinant e2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus e2 gene (cp7_e2alf) - live viral vaccines, immunologicals for suidae - Прасета - За активна имунизация на свинете с 7 седмична възраст и по-нататък, за да се предотврати смъртността и намаляване на инфекции и заболявания, причинени от вируса на класическата чума свинете (csfv). onset of immunity: 14 days after vaccinationduration of immunity: at least 6 months after vaccinationfor active immunisation of breeding females to reduce transplacental infection caused by csfv. onset of immunity: 21 days after vaccinationduration of immunity has not been demonstrated.